Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti‐ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs

Documenti analoghi

• A Review of Hypoxen Pharmacology and Potential to Enhance Sports Performance
  di: Karol Jędrejko, et al.
  Pubblicazione: (2025)
• Estimation of anti‐diabetes drug metformin in Turkiye using wastewater‐based epidemiology
  di: Evsen Yavuz Guzel, et al.
  Pubblicazione: (2024)
• Quantitative analysis of nonsteroidal anti‐inflammatory drugs in dried blood spot from mountain ultra‐trail runners. Contribution of pharmacokinetic models for the interpretation of the results
  di: Mohammad Shafiq Mashal, et al.
  Pubblicazione: (2024)
• Yearly intrasubject variability of hematological biomarkers in elite athletes for the Athlete Biological Passport
  di: Bastien Krumm, et al.
  Pubblicazione: (2024)
• Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography–high‐resolution mass spectrometry (LC–HRMS)
  di: Izabela Lomnicka, et al.
  Pubblicazione: (2024)